JAZZ Projected Dividend Yield
Ord/Jazz Pharmaceuticals Plc ( NASDAQ : JAZZ )Jazz Pharmaceuticals PLC is a biotechnology company. Co. is engaged in developing medicines for people with serious diseases. Co.'s lead marketed products include Xywav (calcium, magnesium, potassium, and sodium oxybates) oral solution, Xyrem (sodium oxybate) oral solution, Epidiolex (cannabidiol) oral solution, Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn), Zepzelca (lurbinectedin), Defitelio (defibrotide sodium) AND Vyxeos (daunorubicin and cytarabine) liposome for injection. 21 YEAR PERFORMANCE RESULTS |
JAZZ Dividend History Detail JAZZ Dividend News JAZZ Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |